ranolazine has been researched along with Tachycardia, Ventricular in 33 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 5 (15.15) | 29.6817 |
2010's | 22 (66.67) | 24.3611 |
2020's | 6 (18.18) | 2.80 |
Authors | Studies |
---|---|
Arafune, T; Dobrev, D; Honjo, H; Kodama, I; Makita, N; Nattel, S; Niwa, R; Sakuma, I; Takanari, H; Tomii, N; Tsuji, Y; Tsuneyama, K; Yamazaki, M | 1 |
Andrade, JG; Deyell, MW | 1 |
Aktas, M; Beck, CA; Bernabei, MA; Daubert, J; Farooq, S; Goldenberg, I; Huang, DT; Mazur, A; McNitt, S; Mitchell, BL; Raitt, M; Rashtian, MR; Vloka, M; Winters, S; Yavin, H; Younis, A; Zareba, W | 1 |
Chan, CS; Chen, SA; Chen, YC; Chen, YJ; Higa, S; Lin, FJ; Lin, YK; Liu, CM; Lu, YY | 1 |
Chang, GJ; Chang, PC; Chou, CC; Chu, Y; Lee, HL; Liu, HT; Wen, MS; Wo, HT; Yen, TH | 1 |
Al-Khatib, SM; Allen LaPointe, NM; Curtis, LH; Hammill, BG; Mi, X; Pokorney, SD | 1 |
Bontempi, L; Cerini, M; Curnis, A; Giacopelli, D; Inama, L; Raweh, A; Salghetti, F; Sciatti, E; Vassanelli, F; Villa, C; Vizzardi, E | 1 |
Albert, CM | 1 |
Aktas, MK; Alexis, JD; Ayala-Parades, F; Baranchuk, A; Beck, CA; Brown, MW; Daubert, JP; Dubuc, M; Feng, C; Haigney, M; Huang, DT; Mazur, A; McNitt, S; McPherson, CA; Mitchell, LB; Moss, AJ; Natale, A; Oakes, D; Piccini, JP; Pyykkonen, K; Raitt, M; Rashtian, MY; Schuger, C; Winters, S; Worley, SJ; Zareba, W; Ziv, O | 1 |
Aidonidis, I; Dipla, K; Hatziefthimiou, A; Moschovidis, V; Simopoulos, V; Stamatiou, R; Stravela, S | 1 |
Aljassim, O; Bonadei, I; Bontempi, L; Curnis, A; D'Aloia, A; Raweh, A; Salghetti, F; Vizzardi, E | 1 |
Dale, RA; Haigney, MC; Krantz, MJ; Schuller, JL; Yeung, E | 1 |
Belardinelli, L; Kanas, AF; Morrow, DA; Nearing, BD; Nieminen, T; Pagotto, VP; Pegler, JR; Scirica, BM; Sobrado, MF; Tavares, C; Umez-Eronini, AA; Verrier, RL | 1 |
Kaliebe, J; Murdock, DK; Overton, N | 1 |
Belardinelli, L; January, CT; Li, H; Rajamani, S; Shryock, JC; Wu, L | 1 |
Belardinelli, L; Bhandari, A; Dhalla, AK; Dow, J; Kloner, RA; Shryock, JC; Wang, WQ | 1 |
Kaliebe, JW; Murdock, DK | 1 |
Freudenberger, R; Levin, V; Martinez, MW; Nanda, S | 1 |
Bhandari, A; Dow, JS; Kloner, RA | 2 |
Patton, KK | 1 |
Belardinelli, L; Braunwald, E; Hedgepeth, CM; Karwatowska-Prokopczuk, E; Morrow, DA; Qin, J; Scirica, BM; Spinar, J; Verheugt, FW; Wang, W | 1 |
Madias, JE | 1 |
Ayalloore, SG; LeLorier, P | 1 |
Belardinelli, L; Budas, GR; Fan, P; Hirakawa, R; Jiang, Z; Kornyeyev, D; Rajamani, S; Shryock, JC; Viatchenko-Karpinski, S; Wu, Y; Yao, L | 1 |
Anderson, JL; Bair, TL; Bunch, TJ; Crandall, BG; Day, JD; Lappe, DL; Mader, KM; Mahapatra, S; May, HT; Molden, J; Muhlestein, JB; Murdock, D; Osborn, JS; Weiss, JP | 1 |
Atack, TC; Hall, L; Lowe, JS; Roden, DM; Stroud, DM; Yang, T | 1 |
Andrikopoulos, G; Tzeis, S | 1 |
Belardinelli, L; Kanas, AF; Nearing, BD; Pagotto, VP; Sobrado, MF; Verrier, RL; Zeng, D | 1 |
Aiba, T; Begley, MJ; Boström, P; Cantley, LC; Das, S; del Monte, F; Ellinor, PT; Graham, EL; Hessler, K; Knight, AC; Morissette, MR; Ottaviano, FG; Quintero, PA; Rosenberg, M; Rosenzweig, A; Tomaselli, GF; Xiao, C | 1 |
Greer-Short, A; Poelzing, S; Radwański, PB | 1 |
Belardinelli, L; Breithardt, G; Eckardt, L; Frommeyer, G; Kaese, S; Kaiser, D; Milberg, P; Osada, N; Rajamani, S; Uphaus, T | 1 |
Antzelevitch, C; Belardinelli, L; Glass, A; Goodrow, RJ; Sicouri, S; Timothy, KW; Zygmunt, AC | 1 |
4 trial(s) available for ranolazine and Tachycardia, Ventricular
Article | Year |
---|---|
Reduction in Ventricular Tachyarrhythmia Burden in Patients Enrolled in the RAID Trial.
Topics: Aged; Defibrillators, Implantable; Humans; Ranolazine; Tachycardia, Ventricular | 2022 |
Ranolazine in High-Risk Patients With Implanted Cardioverter-Defibrillators: The RAID Trial.
Topics: Aged; Cardiovascular Agents; Defibrillators, Implantable; Double-Blind Method; Female; Follow-Up Studies; Humans; Male; Middle Aged; Prospective Studies; Ranolazine; Risk Factors; Tachycardia, Ventricular; Ventricular Fibrillation | 2018 |
Relation of T-wave alternans to mortality and nonsustained ventricular tachycardia in patients with non-ST-segment elevation acute coronary syndrome from the MERLIN-TIMI 36 trial of ranolazine versus placebo.
Topics: Acetanilides; Acute Coronary Syndrome; Aged; Arrhythmias, Cardiac; Brugada Syndrome; Cardiac Conduction System Disease; Death, Sudden, Cardiac; Electrocardiography; Enzyme Inhibitors; Female; Heart Conduction System; Humans; Male; Middle Aged; Piperazines; Placebos; Predictive Value of Tests; Ranolazine; Risk Factors; Tachycardia, Ventricular; Treatment Outcome | 2014 |
Relationship between nonsustained ventricular tachycardia after non-ST-elevation acute coronary syndrome and sudden cardiac death: observations from the metabolic efficiency with ranolazine for less ischemia in non-ST-elevation acute coronary syndrome-thr
Topics: Acetanilides; Acute Coronary Syndrome; Death, Sudden, Cardiac; Electrocardiography; Enzyme Inhibitors; Follow-Up Studies; Humans; Incidence; Myocardial Infarction; Piperazines; Placebos; Prognosis; Proportional Hazards Models; Ranolazine; Risk Factors; Tachycardia, Ventricular; Thrombolytic Therapy; Ventricular Premature Complexes | 2010 |
29 other study(ies) available for ranolazine and Tachycardia, Ventricular
Article | Year |
---|---|
Rotors anchored by refractory islands drive torsades de pointes in an experimental model of electrical storm.
Topics: Action Potentials; Animals; Atrioventricular Block; Defibrillators, Implantable; Disease Models, Animal; Long QT Syndrome; Rabbits; Ranolazine; Tachycardia, Ventricular; Torsades de Pointes | 2022 |
A Role for Ranolazine in the Treatment of Ventricular Arrhythmias?
Topics: Arrhythmias, Cardiac; Humans; Ranolazine; Tachycardia, Ventricular | 2022 |
Modulation of post-pacing action potential duration and contractile responses on ventricular arrhythmogenesis in chloroquine-induced long QT syndrome.
Topics: Action Potentials; Animals; Arrhythmias, Cardiac; Azithromycin; Long QT Syndrome; Rabbits; Ranolazine; Sodium; Tachycardia, Ventricular | 2023 |
Mechanisms of ranolazine pretreatment in preventing ventricular tachyarrhythmias in diabetic db/db mice with acute regional ischemia-reperfusion injury.
Topics: Action Potentials; Animals; Calcium; Calcium-Binding Proteins; Cardiovascular Agents; Diabetes Mellitus, Experimental; Female; Heart Rate; Mice; Myocardial Reperfusion Injury; Ranolazine; Tachycardia, Ventricular | 2020 |
Use of Antiarrhythmic Medications in Medicare Part D Patients With an Implantable Cardioverter-Defibrillator and Ventricular Tachycardia.
Topics: Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Databases, Factual; Death, Sudden, Cardiac; Defibrillators, Implantable; Electric Countershock; Female; Humans; Logistic Models; Male; Medicare Part D; Mexiletine; Ranolazine; Sodium Channel Blockers; Sotalol; Tachycardia, Ventricular; United States | 2017 |
Ranolazine therapy in drug-refractory ventricular arrhythmias.
Topics: Aged; Anti-Arrhythmia Agents; Defibrillators, Implantable; Disease Progression; Drug Resistance; Electric Countershock; Female; Heart Failure; Humans; Male; Middle Aged; Ranolazine; Recurrence; Tachycardia, Ventricular; Time Factors; Treatment Outcome; Ventricular Fibrillation | 2017 |
Ranolazine in Patients With Implantable Cardioverter-Defibrillators: Ready for Prime Time?
Topics: Defibrillators, Implantable; Electric Countershock; Humans; Ranolazine; Tachycardia, Ventricular | 2018 |
Dose-Dependent Effects of Ranolazine on Reentrant Ventricular Arrhythmias Induced After Subacute Myocardial Infarction in Rabbits.
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Heart Rate; Male; Myocardial Infarction; Rabbits; Ranolazine; Refractory Period, Electrophysiological; Tachycardia, Ventricular; Time Factors; Ventricular Fibrillation | 2020 |
Efficacy of ranolazine in a patient with idiopathic dilated cardiomyopathy and electrical storm.
Topics: Acetanilides; Aged; Anti-Arrhythmia Agents; Cardiomyopathy, Dilated; Defibrillators, Implantable; Electrocardiography; Heart Rate; Humans; Male; Piperazines; Ranolazine; Tachycardia, Ventricular; Treatment Outcome; Ventricular Dysfunction, Left | 2013 |
Ranolazine for the suppression of ventricular arrhythmia: a case series.
Topics: Acetanilides; Adult; Aged; Enzyme Inhibitors; Female; Humans; Male; Middle Aged; Piperazines; Ranolazine; Retrospective Studies; Tachycardia, Ventricular; Treatment Outcome; Ventricular Premature Complexes | 2014 |
Ranolozine-induced suppression of ventricular tachycardia in a patient with nonischemic cardiomyopathy: a case report.
Topics: Acetanilides; Aged; Cardiomyopathies; Enzyme Inhibitors; Humans; Male; Myocardial Ischemia; Piperazines; Ranolazine; Tachycardia, Ventricular; Treatment Outcome | 2008 |
Reduction of repolarization reserve unmasks the proarrhythmic role of endogenous late Na(+) current in the heart.
Topics: 4-Aminopyridine; Acetanilides; Action Potentials; Animals; Anti-Arrhythmia Agents; Barium Compounds; Cell Line; Chlorides; Enzyme Inhibitors; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Female; Heart Conduction System; Humans; Kidney; Patch-Clamp Techniques; Piperazines; Piperidines; Potassium Channel Blockers; Pyridines; Rabbits; Ranolazine; Sodium; Sodium Channel Blockers; Sodium Channels; Tachycardia, Ventricular; Tetrodotoxin; Torsades de Pointes | 2009 |
Ranolazine, an antianginal agent, markedly reduces ventricular arrhythmias induced by ischemia and ischemia-reperfusion.
Topics: Acetanilides; Angina Pectoris; Animals; Anti-Arrhythmia Agents; Blood Pressure; Disease Models, Animal; Dose-Response Relationship, Drug; Electrocardiography; Female; Heart Rate; Infusions, Intravenous; Injections, Intravenous; Male; Myocardial Ischemia; Myocardial Reperfusion Injury; Piperazines; Ranolazine; Rats; Rats, Sprague-Dawley; Tachycardia, Ventricular; Time Factors; Ventricular Fibrillation | 2009 |
Suppression of non-sustained ventricular tachycardia with ranolazine: a case report.
Topics: Acetanilides; Aged; Electrocardiography, Ambulatory; Enzyme Inhibitors; Female; Humans; Piperazines; Ranolazine; Tachycardia, Ventricular | 2009 |
Ranolazine--treatment of ventricular tachycardia and symptomatic ventricular premature beats in ischemic cardiomyopathy.
Topics: Acetanilides; Anti-Arrhythmia Agents; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Coronary Artery Bypass; Coronary Artery Disease; Death, Sudden, Cardiac; Defibrillators, Implantable; Dyspnea; Enzyme Inhibitors; Humans; Male; Middle Aged; Piperazines; Ranolazine; Stroke Volume; Tachycardia, Ventricular; Treatment Outcome; Ventricular Premature Complexes | 2010 |
The antianginal agent ranolazine is a potent antiarrhythmic agent that reduces ventricular arrhythmias: through a mechanism favoring inhibition of late sodium channel.
Topics: Acetanilides; Angina Pectoris; Animals; Anti-Arrhythmia Agents; Female; Piperazines; Ranolazine; Rats; Rats, Sprague-Dawley; Sodium Channel Blockers; Tachycardia, Ventricular | 2011 |
The riddle of nonsustained ventricular tachycardia and sudden cardiac death: are we approaching a solution?
Topics: Acetanilides; Death, Sudden, Cardiac; Defibrillators, Implantable; Enzyme Inhibitors; Humans; Piperazines; Predictive Value of Tests; Ranolazine; Risk Factors; Tachycardia, Ventricular; United States | 2010 |
First direct comparison of the late sodium current blocker ranolazine to established antiarrhythmic agents in an ischemia/reperfusion model.
Topics: Acetanilides; Animals; Anti-Arrhythmia Agents; Enzyme Inhibitors; Female; Infusions, Intravenous; Injections, Intravenous; Lidocaine; Myocardial Reperfusion Injury; Piperazines; Random Allocation; Ranolazine; Rats; Rats, Sprague-Dawley; Severity of Illness Index; Sotalol; Statistics, Nonparametric; Tachycardia, Ventricular; Ventricular Fibrillation | 2011 |
Letter by Madias regarding article, "Relationship between nonsustained ventricular tachycardia after non-ST-elevation acute coronary syndrome and sudden cardiac death: observations from the Metabolic Efficiency with Ranolazine for Less Ischemia in Non-ST-
Topics: Acetanilides; Acute Coronary Syndrome; Death, Sudden, Cardiac; Electrocardiography; Enzyme Inhibitors; Heart Rate; Humans; Myocardial Infarction; Myocardial Ischemia; Piperazines; Predictive Value of Tests; Ranolazine; Risk Factors; Stroke Volume; Tachycardia, Ventricular; Thrombolytic Therapy | 2011 |
Letter by Ayalloore and LeLorier regarding article, "Relationship between nonsustained ventricular tachycardia after non-ST-elevation acute coronary syndrome and sudden cardiac death: observations from the Metabolic Efficiency with Ranolazine for Less Isc
Topics: Acetanilides; Acute Coronary Syndrome; Amiodarone; Anti-Arrhythmia Agents; Death, Sudden, Cardiac; Electrocardiography; Enzyme Inhibitors; Heart Rate; Humans; Myocardial Infarction; Myocardial Ischemia; Piperazines; Predictive Value of Tests; Ranolazine; Risk Factors; Stroke Volume; Tachycardia, Ventricular; Thrombolytic Therapy | 2011 |
Nav1.5-dependent persistent Na+ influx activates CaMKII in rat ventricular myocytes and N1325S mice.
Topics: Acetanilides; Amino Acid Substitution; Animals; Animals, Newborn; Calcium; Calcium Signaling; Calcium-Binding Proteins; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Caspase 3; Cell Death; Cell Survival; Cnidarian Venoms; Dose-Response Relationship, Drug; Electrophysiological Phenomena; Female; Gene Expression; Heart Ventricles; Humans; Mice; Mice, Inbred Strains; Mice, Transgenic; Myocytes, Cardiac; NAV1.5 Voltage-Gated Sodium Channel; Peptides; Perfusion; Phosphorylation; Piperazines; Protein Binding; Rabbits; Ranolazine; Rats; Rats, Sprague-Dawley; RNA, Small Interfering; Ryanodine Receptor Calcium Release Channel; Sodium; Sodium Channels; Sodium-Calcium Exchanger; Tachycardia, Ventricular; Tetrodotoxin; Veratridine | 2011 |
Ranolazine reduces ventricular tachycardia burden and ICD shocks in patients with drug-refractory ICD shocks.
Topics: Acetanilides; Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathy, Dilated; Cohort Studies; Defibrillators, Implantable; Drug Therapy, Combination; Electric Countershock; Electrocardiography; Female; Humans; Hypoglycemia; Lidocaine; Male; Mexiletine; Middle Aged; Myocardial Ischemia; Piperazines; Ranolazine; Sotalol; Stroke Volume; Tachycardia, Ventricular; Treatment Outcome | 2011 |
Increased late sodium current contributes to long QT-related arrhythmia susceptibility in female mice.
Topics: Acetanilides; Action Potentials; Animals; Cnidarian Venoms; Disease Models, Animal; Electrocardiography; Female; Genetic Predisposition to Disease; Humans; Long QT Syndrome; Male; Mice; Mice, 129 Strain; Mice, Inbred C57BL; Mice, Knockout; Mice, Transgenic; NAV1.5 Voltage-Gated Sodium Channel; Piperazines; Ranolazine; Risk Factors; Sex Factors; Tachycardia, Ventricular; Time Factors | 2012 |
Antiarrhythmic properties of ranolazine--from bench to bedside.
Topics: Acetanilides; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibrillation; Clinical Trials as Topic; Humans; Piperazines; Ranolazine; Tachycardia, Ventricular | 2012 |
Low doses of ranolazine and dronedarone in combination exert potent protection against atrial fibrillation and vulnerability to ventricular arrhythmias during acute myocardial ischemia.
Topics: Acetanilides; Amiodarone; Animals; Atrial Fibrillation; Chromatography, High Pressure Liquid; Disease Models, Animal; Dronedarone; Drug Therapy, Combination; Electrocardiography; Hemodynamics; Piperazines; Ranolazine; Swine; Tachycardia, Ventricular | 2013 |
Pathological role of serum- and glucocorticoid-regulated kinase 1 in adverse ventricular remodeling.
Topics: Acetanilides; Animals; Cardiomegaly, Exercise-Induced; Cardiomyopathy, Dilated; Consensus Sequence; Disease Models, Animal; Electrocardiography; Enzyme Induction; Heart Failure; Humans; Hypertension; Immediate-Early Proteins; Ion Channel Gating; Mice; Mice, Inbred C57BL; Mice, Transgenic; NAV1.5 Voltage-Gated Sodium Channel; Phosphatidylinositol 3-Kinases; Phosphorylation; Piperazines; Protein Interaction Mapping; Protein Processing, Post-Translational; Protein Serine-Threonine Kinases; Ranolazine; Sodium Channel Blockers; Tachycardia, Ventricular; Ventricular Remodeling | 2012 |
Inhibition of Na+ channels ameliorates arrhythmias in a drug-induced model of Andersen-Tawil syndrome.
Topics: Acetanilides; Action Potentials; Andersen Syndrome; Animals; Calcium Channels; Cytosol; Disease Models, Animal; Dose-Response Relationship, Drug; Electrocardiography; Guinea Pigs; Male; Piperazines; Pyridinium Compounds; Random Allocation; Ranolazine; Sensitivity and Specificity; Sodium Channels; Sodium-Calcium Exchanger; Tachycardia, Ventricular | 2013 |
Effect of ranolazine on ventricular repolarization in class III antiarrhythmic drug-treated rabbits.
Topics: Acetanilides; Action Potentials; Animals; Anti-Arrhythmia Agents; Disease Models, Animal; Electrocardiography; Female; Heart Conduction System; Heart Ventricles; Piperazines; Rabbits; Ranolazine; Tachycardia, Ventricular | 2012 |
Cellular basis for the electrocardiographic and arrhythmic manifestations of Timothy syndrome: effects of ranolazine.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Acetanilides; Action Potentials; Analysis of Variance; Animals; Anti-Arrhythmia Agents; Calcium Channel Agonists; Disease Models, Animal; Dogs; Electrocardiography; Endocardium; Enzyme Inhibitors; Heart Ventricles; Long QT Syndrome; Myocytes, Cardiac; Patch-Clamp Techniques; Pericardium; Piperazines; Ranolazine; Tachycardia, Ventricular; Torsades de Pointes; Ventricular Premature Complexes | 2007 |